|
Variables
|
Low binary
|
High binary
|
p value
|
|---|
|
( 4 h TG < 3.47 mmol/L)
|
( 4 h TG ≥ 3.47 mmol/L)
|
|---|
|
( N = 219)
|
( N = 219)
|
|---|
|
Age (years)
|
30.98 ± 3.80
|
30.58 ± 3.99
|
0.77
|
|
Gravidity
|
2.39 ± 1.19
|
2.23 ± 1.22
|
0.33
|
|
Parity
|
0.56 ± 0.80
|
0.53 ± 0.71
|
0.49
|
|
Prepregnancy BMI (kg/m2)
|
21.45 (19.81–23.53)
|
21.78 (20.31–24.45)
|
0.34
|
|
Systolic Blood Pressure (mmHg)
|
114.93 ± 11.26
|
113.49 ± 11.05
|
0.84
|
|
Diastolic Blood Pressure (mmHg)
|
68.17 ± 7.73
|
68.08 ± 10.60
|
0.76
|
|
HbA1c (%)
|
5.0 (4.9–5.3)
|
5.1 (4.9–5.3)
|
0.1
|
|
FPG (mmol/L)
|
4.60 ± 0.34
|
4.75 ± 0.47
|
0.01
|
|
1 h PG (mmol/L)
|
7.87 ± 1.71
|
8.22 ± 1.87
|
0.16
|
|
2 h PG (mmol/L)
|
6.70 ± 1.31
|
7.03 ± 1.43
|
0.35
|
|
Total Cholesterol (mmol/L)
|
5.98 (5.61–6.68)
|
5.76 (5.29–6.66)
|
0.14
|
|
HDL-C (mmol/L)
|
2.07 ± 0.39
|
1.83 ± 0.38
|
< 0.01
|
|
LDL-C (mmol/L)
|
3.14 ± 0.76
|
2.95 ± 1.00
|
0.04
|
|
HOMA-β (%)
|
124.53 (85.85–164.40)
|
121.32 (96.58–168.19)
|
0.29
|
|
HOMA-IR
|
1.23 (0.96–1.71)
|
1.58 (1.15–2.23)
|
< 0.01
|
|
Neonatal weight (g)
|
3270.34 ± 428.62
|
3308.29 ± 407.14
|
0.08
|
|
Preeclampsia(%)
|
4 (1.80%)
|
20 (9.10%)
|
0.015
|
|
Adverse Neonatal Outcomes(%)
|
48 (22.00%)
|
64 (29.10%)
|
0.23
|
|
Creatinine
|
53.86 ± 7.84
|
54.65 ± 6.28
|
0.07
|
- Data are expressed as the mean ± standard deviation or median (interquartile range), or n (%). BMI body mass index, FPG fasting plasma glucose, HbA1c hemoglobin A1c, HDL-C high-density lipoprotein-cholesterol, HOMA-IR homeostasis model assessment for insulin resistance index, HOMA-β homeostasis model assessment for β cell function, LDL-C low-density lipoprotein-cholesterol, TG triglyceride, 1hPG 1-h plasma glucose, 2hPG 2-h plasma glucose
